nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Decitabine—Gemcitabine—urinary bladder cancer	0.774	1	CrCrCtD
Telbivudine—Floxuridine—TYMP—urinary bladder cancer	0.004	0.252	CrCbGaD
Telbivudine—Trifluridine—TYMP—urinary bladder cancer	0.00318	0.2	CrCbGaD
Telbivudine—Zidovudine—TERT—urinary bladder cancer	0.0022	0.139	CrCbGaD
Telbivudine—Floxuridine—TYMS—urinary bladder cancer	0.00188	0.118	CrCbGaD
Telbivudine—Zidovudine—UGT2B7—urinary bladder cancer	0.00171	0.108	CrCbGaD
Telbivudine—Trifluridine—TYMS—urinary bladder cancer	0.00149	0.094	CrCbGaD
Telbivudine—Cladribine—RRM2—urinary bladder cancer	0.00142	0.0894	CrCbGaD
Telbivudine—Pain—Thiotepa—urinary bladder cancer	0.000425	0.00202	CcSEcCtD
Telbivudine—Discomfort—Fluorouracil—urinary bladder cancer	0.000424	0.00202	CcSEcCtD
Telbivudine—Back pain—Etoposide—urinary bladder cancer	0.000423	0.00201	CcSEcCtD
Telbivudine—Muscle spasms—Etoposide—urinary bladder cancer	0.000421	0.002	CcSEcCtD
Telbivudine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00041	0.00195	CcSEcCtD
Telbivudine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00041	0.00195	CcSEcCtD
Telbivudine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00041	0.00195	CcSEcCtD
Telbivudine—Pain in extremity—Epirubicin—urinary bladder cancer	0.000408	0.00194	CcSEcCtD
Telbivudine—Myalgia—Cisplatin—urinary bladder cancer	0.000407	0.00194	CcSEcCtD
Telbivudine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000407	0.00193	CcSEcCtD
Telbivudine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000406	0.00193	CcSEcCtD
Telbivudine—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000406	0.00193	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000404	0.00192	CcSEcCtD
Telbivudine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000403	0.00192	CcSEcCtD
Telbivudine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000403	0.00192	CcSEcCtD
Telbivudine—Discomfort—Cisplatin—urinary bladder cancer	0.000402	0.00191	CcSEcCtD
Telbivudine—Migraine—Epirubicin—urinary bladder cancer	0.000401	0.00191	CcSEcCtD
Telbivudine—Renal impairment—Doxorubicin—urinary bladder cancer	0.000396	0.00188	CcSEcCtD
Telbivudine—Malaise—Etoposide—urinary bladder cancer	0.000395	0.00188	CcSEcCtD
Telbivudine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000393	0.00187	CcSEcCtD
Telbivudine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000393	0.00187	CcSEcCtD
Telbivudine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000382	0.00182	CcSEcCtD
Telbivudine—Cough—Etoposide—urinary bladder cancer	0.000382	0.00182	CcSEcCtD
Telbivudine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000382	0.00182	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000381	0.00181	CcSEcCtD
Telbivudine—Skin disorder—Cisplatin—urinary bladder cancer	0.000379	0.0018	CcSEcCtD
Telbivudine—Insomnia—Gemcitabine—urinary bladder cancer	0.000378	0.0018	CcSEcCtD
Telbivudine—Pain in extremity—Doxorubicin—urinary bladder cancer	0.000377	0.00179	CcSEcCtD
Telbivudine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000376	0.00179	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000375	0.00178	CcSEcCtD
Telbivudine—Chest pain—Etoposide—urinary bladder cancer	0.000373	0.00177	CcSEcCtD
Telbivudine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000372	0.00177	CcSEcCtD
Telbivudine—Insomnia—Fluorouracil—urinary bladder cancer	0.000372	0.00177	CcSEcCtD
Telbivudine—Migraine—Doxorubicin—urinary bladder cancer	0.000371	0.00177	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00037	0.00176	CcSEcCtD
Telbivudine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000369	0.00176	CcSEcCtD
Telbivudine—Discomfort—Etoposide—urinary bladder cancer	0.000368	0.00175	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000367	0.00175	CcSEcCtD
Telbivudine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000364	0.00173	CcSEcCtD
Telbivudine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000362	0.00172	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000361	0.00172	CcSEcCtD
Telbivudine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000361	0.00172	CcSEcCtD
Telbivudine—Fatigue—Gemcitabine—urinary bladder cancer	0.000361	0.00172	CcSEcCtD
Telbivudine—Gastritis—Epirubicin—urinary bladder cancer	0.000361	0.00172	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000359	0.00171	CcSEcCtD
Telbivudine—Muscular weakness—Epirubicin—urinary bladder cancer	0.000359	0.00171	CcSEcCtD
Telbivudine—Pain—Gemcitabine—urinary bladder cancer	0.000358	0.0017	CcSEcCtD
Telbivudine—Asthenia—Thiotepa—urinary bladder cancer	0.000357	0.0017	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000355	0.00169	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000355	0.00169	CcSEcCtD
Telbivudine—Abdominal distension—Epirubicin—urinary bladder cancer	0.000355	0.00169	CcSEcCtD
Telbivudine—Influenza—Epirubicin—urinary bladder cancer	0.000352	0.00168	CcSEcCtD
Telbivudine—Neutropenia—Methotrexate—urinary bladder cancer	0.000352	0.00167	CcSEcCtD
Telbivudine—Pruritus—Thiotepa—urinary bladder cancer	0.000352	0.00167	CcSEcCtD
Telbivudine—Pain—Fluorouracil—urinary bladder cancer	0.000352	0.00167	CcSEcCtD
Telbivudine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00035	0.00167	CcSEcCtD
Telbivudine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00035	0.00166	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00035	0.00166	CcSEcCtD
Telbivudine—Skin disorder—Etoposide—urinary bladder cancer	0.000347	0.00165	CcSEcCtD
Telbivudine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000345	0.00164	CcSEcCtD
Telbivudine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000344	0.00164	CcSEcCtD
Telbivudine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00034	0.00162	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00034	0.00162	CcSEcCtD
Telbivudine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000339	0.00161	CcSEcCtD
Telbivudine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000337	0.0016	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000337	0.0016	CcSEcCtD
Telbivudine—Gastritis—Doxorubicin—urinary bladder cancer	0.000334	0.00159	CcSEcCtD
Telbivudine—Pain—Cisplatin—urinary bladder cancer	0.000334	0.00159	CcSEcCtD
Telbivudine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000333	0.00158	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000333	0.00158	CcSEcCtD
Telbivudine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000331	0.00157	CcSEcCtD
Telbivudine—Renal failure—Methotrexate—urinary bladder cancer	0.00033	0.00157	CcSEcCtD
Telbivudine—Neutropenia—Epirubicin—urinary bladder cancer	0.000329	0.00157	CcSEcCtD
Telbivudine—Dizziness—Thiotepa—urinary bladder cancer	0.000329	0.00156	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000328	0.00156	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000327	0.00156	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—urinary bladder cancer	0.000326	0.00155	CcSEcCtD
Telbivudine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000325	0.00155	CcSEcCtD
Telbivudine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000321	0.00153	CcSEcCtD
Telbivudine—Paraesthesia—Etoposide—urinary bladder cancer	0.000321	0.00153	CcSEcCtD
Telbivudine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000317	0.00151	CcSEcCtD
Telbivudine—Vomiting—Thiotepa—urinary bladder cancer	0.000316	0.0015	CcSEcCtD
Telbivudine—Rash—Thiotepa—urinary bladder cancer	0.000314	0.00149	CcSEcCtD
Telbivudine—Dermatitis—Thiotepa—urinary bladder cancer	0.000313	0.00149	CcSEcCtD
Telbivudine—Headache—Thiotepa—urinary bladder cancer	0.000312	0.00148	CcSEcCtD
Telbivudine—Renal failure—Epirubicin—urinary bladder cancer	0.000309	0.00147	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000308	0.00147	CcSEcCtD
Telbivudine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000308	0.00147	CcSEcCtD
Telbivudine—Fatigue—Etoposide—urinary bladder cancer	0.000308	0.00147	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000308	0.00146	CcSEcCtD
Telbivudine—Pain—Etoposide—urinary bladder cancer	0.000306	0.00145	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000305	0.00145	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000303	0.00144	CcSEcCtD
Telbivudine—Hepatitis—Methotrexate—urinary bladder cancer	0.000301	0.00143	CcSEcCtD
Telbivudine—Asthenia—Gemcitabine—urinary bladder cancer	0.0003	0.00143	CcSEcCtD
Telbivudine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000299	0.00142	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000297	0.00141	CcSEcCtD
Telbivudine—Pruritus—Gemcitabine—urinary bladder cancer	0.000296	0.00141	CcSEcCtD
Telbivudine—Nausea—Thiotepa—urinary bladder cancer	0.000295	0.00141	CcSEcCtD
Telbivudine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000294	0.0014	CcSEcCtD
Telbivudine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000292	0.00139	CcSEcCtD
Telbivudine—Pruritus—Fluorouracil—urinary bladder cancer	0.000291	0.00138	CcSEcCtD
Telbivudine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000286	0.00136	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—urinary bladder cancer	0.000286	0.00136	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000285	0.00135	CcSEcCtD
Telbivudine—Abdominal pain—Etoposide—urinary bladder cancer	0.000282	0.00134	CcSEcCtD
Telbivudine—Body temperature increased—Etoposide—urinary bladder cancer	0.000282	0.00134	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—urinary bladder cancer	0.000282	0.00134	CcSEcCtD
Telbivudine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000282	0.00134	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000281	0.00133	CcSEcCtD
Telbivudine—Asthenia—Cisplatin—urinary bladder cancer	0.00028	0.00133	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—urinary bladder cancer	0.00028	0.00133	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000277	0.00132	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000275	0.00131	CcSEcCtD
Telbivudine—Dizziness—Fluorouracil—urinary bladder cancer	0.000272	0.00129	CcSEcCtD
Telbivudine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000272	0.00129	CcSEcCtD
Telbivudine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000267	0.00127	CcSEcCtD
Telbivudine—Vomiting—Gemcitabine—urinary bladder cancer	0.000266	0.00127	CcSEcCtD
Telbivudine—Rash—Gemcitabine—urinary bladder cancer	0.000264	0.00125	CcSEcCtD
Telbivudine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000264	0.00125	CcSEcCtD
Telbivudine—Malnutrition—Methotrexate—urinary bladder cancer	0.000262	0.00125	CcSEcCtD
Telbivudine—Headache—Gemcitabine—urinary bladder cancer	0.000262	0.00125	CcSEcCtD
Telbivudine—Vomiting—Fluorouracil—urinary bladder cancer	0.000262	0.00124	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000261	0.00124	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00026	0.00123	CcSEcCtD
Telbivudine—Rash—Fluorouracil—urinary bladder cancer	0.000259	0.00123	CcSEcCtD
Telbivudine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000259	0.00123	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000259	0.00123	CcSEcCtD
Telbivudine—Headache—Fluorouracil—urinary bladder cancer	0.000258	0.00123	CcSEcCtD
Telbivudine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000257	0.00122	CcSEcCtD
Telbivudine—Asthenia—Etoposide—urinary bladder cancer	0.000256	0.00122	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000256	0.00122	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000254	0.00121	CcSEcCtD
Telbivudine—Back pain—Methotrexate—urinary bladder cancer	0.000254	0.00121	CcSEcCtD
Telbivudine—Pruritus—Etoposide—urinary bladder cancer	0.000253	0.0012	CcSEcCtD
Telbivudine—Nausea—Gemcitabine—urinary bladder cancer	0.000249	0.00118	CcSEcCtD
Telbivudine—Vomiting—Cisplatin—urinary bladder cancer	0.000248	0.00118	CcSEcCtD
Telbivudine—Rash—Cisplatin—urinary bladder cancer	0.000246	0.00117	CcSEcCtD
Telbivudine—Dermatitis—Cisplatin—urinary bladder cancer	0.000246	0.00117	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—urinary bladder cancer	0.000245	0.00117	CcSEcCtD
Telbivudine—Diarrhoea—Etoposide—urinary bladder cancer	0.000244	0.00116	CcSEcCtD
Telbivudine—Nausea—Fluorouracil—urinary bladder cancer	0.000244	0.00116	CcSEcCtD
Telbivudine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000243	0.00116	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—urinary bladder cancer	0.00024	0.00114	CcSEcCtD
Telbivudine—Back pain—Epirubicin—urinary bladder cancer	0.000237	0.00113	CcSEcCtD
Telbivudine—Malaise—Methotrexate—urinary bladder cancer	0.000236	0.00112	CcSEcCtD
Telbivudine—Dizziness—Etoposide—urinary bladder cancer	0.000236	0.00112	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000236	0.00112	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000235	0.00112	CcSEcCtD
Telbivudine—Nausea—Cisplatin—urinary bladder cancer	0.000232	0.0011	CcSEcCtD
Telbivudine—Cough—Methotrexate—urinary bladder cancer	0.000229	0.00109	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000228	0.00108	CcSEcCtD
Telbivudine—Vomiting—Etoposide—urinary bladder cancer	0.000227	0.00108	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000227	0.00108	CcSEcCtD
Telbivudine—Rash—Etoposide—urinary bladder cancer	0.000225	0.00107	CcSEcCtD
Telbivudine—Dermatitis—Etoposide—urinary bladder cancer	0.000225	0.00107	CcSEcCtD
Telbivudine—Headache—Etoposide—urinary bladder cancer	0.000224	0.00106	CcSEcCtD
Telbivudine—Arthralgia—Methotrexate—urinary bladder cancer	0.000223	0.00106	CcSEcCtD
Telbivudine—Chest pain—Methotrexate—urinary bladder cancer	0.000223	0.00106	CcSEcCtD
Telbivudine—Myalgia—Methotrexate—urinary bladder cancer	0.000223	0.00106	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000222	0.00106	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000222	0.00105	CcSEcCtD
Telbivudine—Malaise—Epirubicin—urinary bladder cancer	0.000221	0.00105	CcSEcCtD
Telbivudine—Discomfort—Methotrexate—urinary bladder cancer	0.000221	0.00105	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—urinary bladder cancer	0.00022	0.00104	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000218	0.00104	CcSEcCtD
Telbivudine—Cough—Epirubicin—urinary bladder cancer	0.000214	0.00102	CcSEcCtD
Telbivudine—Nausea—Etoposide—urinary bladder cancer	0.000212	0.00101	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000211	0.001	CcSEcCtD
Telbivudine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00021	0.000998	CcSEcCtD
Telbivudine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00021	0.000997	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—urinary bladder cancer	0.000209	0.000994	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—urinary bladder cancer	0.000209	0.000994	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—urinary bladder cancer	0.000209	0.000994	CcSEcCtD
Telbivudine—Skin disorder—Methotrexate—urinary bladder cancer	0.000208	0.000989	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000207	0.000987	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—urinary bladder cancer	0.000206	0.000982	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—urinary bladder cancer	0.000205	0.000974	CcSEcCtD
Telbivudine—Cough—Doxorubicin—urinary bladder cancer	0.000198	0.000943	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000196	0.000934	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000196	0.000933	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000195	0.000927	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—urinary bladder cancer	0.000195	0.000925	CcSEcCtD
Telbivudine—Insomnia—Methotrexate—urinary bladder cancer	0.000194	0.000921	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—urinary bladder cancer	0.000193	0.00092	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000193	0.00092	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—urinary bladder cancer	0.000193	0.00092	CcSEcCtD
Telbivudine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000192	0.000914	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000192	0.000913	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—urinary bladder cancer	0.000191	0.000909	CcSEcCtD
Telbivudine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000188	0.000896	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000185	0.000879	CcSEcCtD
Telbivudine—Fatigue—Methotrexate—urinary bladder cancer	0.000185	0.000878	CcSEcCtD
Telbivudine—Pain—Methotrexate—urinary bladder cancer	0.000183	0.000871	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000182	0.000868	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000182	0.000864	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000181	0.000863	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—urinary bladder cancer	0.000181	0.000862	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—urinary bladder cancer	0.00018	0.000856	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—urinary bladder cancer	0.00018	0.000855	CcSEcCtD
Telbivudine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000176	0.000839	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000176	0.000839	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000175	0.000832	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000173	0.000822	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—urinary bladder cancer	0.000173	0.000821	CcSEcCtD
Telbivudine—Pain—Epirubicin—urinary bladder cancer	0.000171	0.000815	CcSEcCtD
Telbivudine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000169	0.000805	CcSEcCtD
Telbivudine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000169	0.000805	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000169	0.000803	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—urinary bladder cancer	0.000168	0.000797	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000166	0.000792	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000165	0.000785	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000164	0.000779	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000163	0.000776	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000761	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—urinary bladder cancer	0.00016	0.00076	CcSEcCtD
Telbivudine—Pain—Doxorubicin—urinary bladder cancer	0.000158	0.000754	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000158	0.000753	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000158	0.000753	CcSEcCtD
Telbivudine—Asthenia—Methotrexate—urinary bladder cancer	0.000154	0.00073	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000153	0.000726	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000152	0.000721	CcSEcCtD
Telbivudine—Pruritus—Methotrexate—urinary bladder cancer	0.000151	0.00072	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000147	0.000697	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000147	0.000697	CcSEcCtD
Telbivudine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000146	0.000697	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—urinary bladder cancer	0.000144	0.000684	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—urinary bladder cancer	0.000142	0.000674	CcSEcCtD
Telbivudine—Dizziness—Methotrexate—urinary bladder cancer	0.000142	0.000673	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000137	0.000652	CcSEcCtD
Telbivudine—Vomiting—Methotrexate—urinary bladder cancer	0.000136	0.000647	CcSEcCtD
Telbivudine—Rash—Methotrexate—urinary bladder cancer	0.000135	0.000642	CcSEcCtD
Telbivudine—Dermatitis—Methotrexate—urinary bladder cancer	0.000135	0.000641	CcSEcCtD
Telbivudine—Headache—Methotrexate—urinary bladder cancer	0.000134	0.000638	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—urinary bladder cancer	0.000133	0.000632	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—urinary bladder cancer	0.000132	0.00063	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—urinary bladder cancer	0.000131	0.000624	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—urinary bladder cancer	0.000127	0.000606	CcSEcCtD
Telbivudine—Nausea—Methotrexate—urinary bladder cancer	0.000127	0.000605	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000127	0.000603	CcSEcCtD
Telbivudine—Rash—Epirubicin—urinary bladder cancer	0.000126	0.000601	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—urinary bladder cancer	0.000126	0.0006	CcSEcCtD
Telbivudine—Headache—Epirubicin—urinary bladder cancer	0.000125	0.000597	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—urinary bladder cancer	0.000123	0.000583	CcSEcCtD
Telbivudine—Nausea—Epirubicin—urinary bladder cancer	0.000119	0.000566	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—urinary bladder cancer	0.000118	0.00056	CcSEcCtD
Telbivudine—Rash—Doxorubicin—urinary bladder cancer	0.000117	0.000556	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000117	0.000555	CcSEcCtD
Telbivudine—Headache—Doxorubicin—urinary bladder cancer	0.000116	0.000552	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—urinary bladder cancer	0.00011	0.000524	CcSEcCtD
